Results 11 to 20 of about 26,503 (228)

New Strategies for Improving Budesonide Skin Retention [PDF]

Pharmaceutics, 2021
The aim of this work was to evaluate the ex vivo effect of the combination of two strategies, complexation with cyclodextrin, and poloxamer hydrogels, for improving water solubility in the dermal absorption of budesonide.
Cristina Padula, Ian Pompermayer Machado, Aryane Alves Vigato, Daniele Ribeiro de Araujo   +3 more
doaj   +3 more sources

Risk of pneumonia with budesonide-containing treatments in COPD: an individual patient-level pooled analysis of interventional studies

International Journal of COPD, 2017
Sally Hollis,1 Carin Jorup,2 Dan Lythgoe,3 Gunnar Martensson,2 Pontus Regnell,2 Göran Eckerwall2 1AstraZeneca R&D, Alderley Park, Macclesfield, UK; 2AstraZeneca R&D, Gothenburg, Sweden; 3Phastar, Chiswick, London, UK Background: Concerns ...
Hollis S, Jorup C, Lythgoe D, Martensson G, Regnell P, Eckerwall G   +5 more
doaj   +1 more source

Effects of Budesonide on Coronavirus-Associated Receptor and Immune-Mediator Expression in Human Lung Microvascular Endothelial Cells [PDF]

Medicina
Background and Objectives: Inhaled corticosteroids exert broad immunomodulatory effects in patients with chronic airway diseases. However, their direct impact on pulmonary endothelial immune responses and coronavirus-associated receptor expression ...
Izabela Ławska, Adrian Bekier, Maciej Chałubiński, Aleksandra Wardzyńska   +3 more
doaj   +2 more sources

Decreased frequency of adenoidectomy by a 12-week nasal budesonide treatment

Therapeutics and Clinical Risk Management, 2017
Haiyu Hong,1,* Fenghong Chen,2,* Xiaobin Zheng,3 Wei Liao,1 Zhenpeng Liao,1 Yujie Cao,2 Haixin He,1 Zhe Zhu,4,5 Yunping Fan1 1Department of Otolaryngology and Head Neck Surgery of 5th Hospital, Affiliated with Sun Yat-sen University, Zhuhai, 2Department
Hong H, Chen F, Zheng X, Liao W, Liao Z, Cao Y, He H, Zhu Z, Fan Y   +8 more
doaj   +1 more source

Increased failure of budesonide MMX for ulcerative colitis during the COVID-19 pandemic: a population-based study [PDF]

Therapeutic Advances in Gastroenterology
Background: Corticosteroids induce remission in ulcerative colitis (UC) but are associated with adverse effects, including prednisone ⩾20 mg/day associated with serious COVID-19 outcomes.
Stephanie Coward, Karen J. B. Martins, Scott Klarenbach, Lawrence P. Richer, Christopher Ma, Remo Panaccione, Cynthia H. Seow, Karen Kroeker, Frank Hoentjen, Laura E. Targownik, Gilaad G. Kaplan   +10 more
doaj   +2 more sources

Long-term safety and efficacy of budesonide in the treatment of ulcerative colitis

Clinical and Experimental Gastroenterology, 2014
Marisa Iborra,1 Diego Álvarez-Sotomayor,2 Pilar Nos1 1Gastroenterology Unit, Department of Digestive Disease, Centro de investigación biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), La Fe University and ...
Iborra M, Álvarez-Sotomayor D, Nos P   +2 more
doaj   +1 more source

Cost-effectiveness of as-needed budesonide-formoterol in adults with mild asthma: the Novel START trial [PDF]

ERJ Open Research
Background The Global Initiative for Asthma recommends as-needed combination inhaled corticosteroid-formoterol reliever for mild asthma. Its cost-effectiveness is uncertain outside double-blind regulatory trials.
William Leung, Helen K. Reddel, Tiffany Hung, Mark Weatherall, Ilka Pelzer, Mark Holliday, Trudy Sullivan, Tim Harrison, Ian D. Pavord, Michael G. Baker, Stefan Ebmeier, Alberto Papi, Richard Beasley, Robert J. Hancox   +13 more
doaj   +2 more sources

Is It Really Feasible to Use Budesonide–Formoterol as Needed for Mild Persistent Asthma? A Systematic Review and Meta-Analysis

Frontiers in Pharmacology, 2021
Background: Previous studies suggest that inhaled budesonide-formoterol used as needed could effectively reduce the severe exacerbation of mild persistent asthma.
Xiang Tong, Tao Liu, Zhenzhen Li, Sitong Liu, Hong Fan   +4 more
doaj   +1 more source

Surfactant-Assisted Distal Pulmonary Distribution of Budesonide Revealed by Mass Spectrometry Imaging

Pharmaceutics, 2021
Direct lung administration of budesonide in combination with surfactant reduces the incidence of bronchopulmonary dysplasia. Although the therapy is currently undergoing clinical development, the lung distribution of budesonide throughout the premature ...
Riccardo Zecchi, Pietro Franceschi, Laura Tigli, Barbara Pioselli, Valentina Mileo, Xabier Murgia, Fabrizio Salomone, Giuseppe Pieraccini, Haruo Usada, Augusto F. Schmidt, Noah H. Hillman, Matthew W. Kemp, Alan H. Jobe   +12 more
doaj   +1 more source

Simultaneous intratracheal administration of surfactant and budesonide in the prevention of bronchopulmonary dysplasia in the treatment of respiratory distress syndrome in premature infants [PDF]

, 2023
Background: Premature birth is an important issue in developing and developed countries. The purpose of this study is to investigate the effect of budesonide and surfactant in the treatment of respiratory distress syndrome and the prevention of ...
Norouzi, Elahe, Aminyan Daryasari, Arezoo, Maleki, Mahsa, Farhanian, Fahimeh, Kashaki, Mandana   +4 more
core   +1 more source